Cardioprotective mechanisms of sodium-glucose cotransporter 2 inhibitors

The findings of large-scale cardiovascular outcome trials have been demonstrated that sodium-glucose cotransporter 2 ­inhibitors (iSGLT-2) have shown beneficial cardiovascular effects. In this review proposed mechanisms underlying iSGLT-2-associated cardiovascular benefits have been discussed: haemo...

Full description

Saved in:
Bibliographic Details
Main Authors: A. M. Mkrtumyan, T. N. Markova, N. K. Mishchenko
Format: article
Language:EN
RU
Published: Endocrinology Research Centre 2021
Subjects:
Online Access:https://doaj.org/article/97d2e8917f464f4da6b7cc5a343337ff
Tags: Add Tag
No Tags, Be the first to tag this record!